Biotech MSB has fallen -40% over the last 12-months but history shows us this is an extremely volatile stock which doubles and halves almost as often as the sun rises! This is not a stock for MM, the companies losing money plus revenues are falling and costs rising, all too hard at present although I’m confident it will again double from some level at one stage before Christmas.
MM is neutral MSB
Add To Hit List
